Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bayer describes novel guanylate cyclase activators with utility in cognition disorders

May 20, 2004

Novel CRF antagonists prepared and tested at BMS

May 20, 2004

Elan and Vernalis finalize agreement regarding Frova

May 20, 2004

Pozen and GSK move new migraine treatment into phase III

May 20, 2004

Effective use of immediate-release and modified-release indiplon to treat insomnia

May 20, 2004

New 5-HT6 antagonists prepared and tested by Roche team

May 19, 2004

Elan scientists describe beta-secretase inhibitors for AD therapy

May 18, 2004

Pfizer claims dual D2/5-HT2A antagonists and their use in schizophrenia

May 18, 2004

GSK presents two series of cannabinoid CB2 agonists for pain and other uses

May 18, 2004

Mobic to be marketed in Japan by Daiichi Pharmaceutical

May 18, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...